Skip to main content

Lassa fever: Vaccine candidate, Nigeria update

Submitted by lsekela on May 23, 2019 - 10:24 AM

Inovio Pharmaceuticals announced it has dosed subjects in Phase 1 of the first-in-human clinical trial to evaluate its DNA candidate vaccine to prevent infection from the Lassa virus.

Content Source:

Outbreak News Today

Content Author: